Your browser doesn't support javascript.
loading
Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer.
Poonawalla, Insiya B; Lairson, David R; Chan, Wenyaw; Piller, Linda B; Du, Xianglin L.
Affiliation
  • Poonawalla IB; Department of Epidemiology, Human Genetics, and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Lairson DR; Department of Management Policy and Community Health, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address: David.R.Lairson@uth.tmc.edu.
  • Chan W; Department of Biostatistics, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Piller LB; Department of Epidemiology, Human Genetics, and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Du XL; Department of Epidemiology, Human Genetics, and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
Value Health ; 18(4): 387-95, 2015 Jun.
Article in En | MEDLINE | ID: mdl-26091592
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cost-Benefit Analysis / SEER Program / Neoadjuvant Therapy / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2015 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cost-Benefit Analysis / SEER Program / Neoadjuvant Therapy / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2015 Document type: Article Affiliation country: United States Country of publication: United States